Biosimilar medicines do not have clinically significant differences with the reference product. This means that the same safety and efficacy can be expected with a biosimilar throughout a treatment as with the reference product.
Industry news
Biosimilar medicines do not have clinically significant differences with the reference product. This means that the same safety and efficacy can be expected with a biosimilar throughout a treatment as with the reference product.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.